PRIO – a prospective integrative oncology registry: trial protocol
BackgroundIntegrative Oncology (IO) – the use of lifestyle modifications, mind-body practices and natural products in oncology – is increasingly asked for by patients. The evidence base of IO is growing and IO measures are included in national guidelines. Still, many questions about IO remain unansw...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1455281/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850245958870237184 |
|---|---|
| author | Paul G. Werthmann Paul G. Werthmann Paul G. Werthmann Ann-Kathrin Lederer Ann-Kathrin Lederer Hannah Maja Figura Klaus Kramer |
| author_facet | Paul G. Werthmann Paul G. Werthmann Paul G. Werthmann Ann-Kathrin Lederer Ann-Kathrin Lederer Hannah Maja Figura Klaus Kramer |
| author_sort | Paul G. Werthmann |
| collection | DOAJ |
| description | BackgroundIntegrative Oncology (IO) – the use of lifestyle modifications, mind-body practices and natural products in oncology – is increasingly asked for by patients. The evidence base of IO is growing and IO measures are included in national guidelines. Still, many questions about IO remain unanswered or still show a poor evidence base.MethodData about demography, socioeconomic status, cancer disease and therapy, integrative oncology measures and patient reported outcomes will be collected in regular visits in oncological patients at the University Cancer Center Ulm, Germany. An expansion to further study centers is planned. After one year and at regular intervals, the registry will be evaluated and adapted accordingly.DiscussionThe PRIO registry builds a solid data base to evaluate the use of integrative oncology measures in cancer patients. It includes patient reported outcome measures to investigate quality of life and satisfaction with health services in this population. The registry aims to enhance transparency in IO use and wants to inform future research in IO. The trial has been registered in the German Clinical Trials Register (DRKS) under the ID DRKS00033250 and in the studyBox of the German Cancer Association under the ID ST-U173 on 18th December 2023. The trial was approved by the ethics committee of the University Medical Center Ulm under the number 375/23 on 7th December 2023. |
| format | Article |
| id | doaj-art-d8562cd86d834b4c87bcbe6e245618e5 |
| institution | OA Journals |
| issn | 2234-943X |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Oncology |
| spelling | doaj-art-d8562cd86d834b4c87bcbe6e245618e52025-08-20T01:59:18ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2024-12-011410.3389/fonc.2024.14552811455281PRIO – a prospective integrative oncology registry: trial protocolPaul G. Werthmann0Paul G. Werthmann1Paul G. Werthmann2Ann-Kathrin Lederer3Ann-Kathrin Lederer4Hannah Maja Figura5Klaus Kramer6Research Group Integrative Medicine, Department of General and Visceral Surgery, University Hospital Ulm, Ulm, GermanyCenter for Complementary Medicine, Department of Medicine II, Medical Center—University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, GermanyInstitute for Applied Epistemology and Medical Methodology, University of Witten/Herdecke, Freiburg, GermanyCenter for Complementary Medicine, Department of Medicine II, Medical Center—University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, GermanyDepartment of General, Visceral and Transplant Surgery, University Medical Center of the Johannes Gutenberg University, Mainz, GermanyResearch Group Integrative Medicine, Department of General and Visceral Surgery, University Hospital Ulm, Ulm, GermanyResearch Group Integrative Medicine, Department of General and Visceral Surgery, University Hospital Ulm, Ulm, GermanyBackgroundIntegrative Oncology (IO) – the use of lifestyle modifications, mind-body practices and natural products in oncology – is increasingly asked for by patients. The evidence base of IO is growing and IO measures are included in national guidelines. Still, many questions about IO remain unanswered or still show a poor evidence base.MethodData about demography, socioeconomic status, cancer disease and therapy, integrative oncology measures and patient reported outcomes will be collected in regular visits in oncological patients at the University Cancer Center Ulm, Germany. An expansion to further study centers is planned. After one year and at regular intervals, the registry will be evaluated and adapted accordingly.DiscussionThe PRIO registry builds a solid data base to evaluate the use of integrative oncology measures in cancer patients. It includes patient reported outcome measures to investigate quality of life and satisfaction with health services in this population. The registry aims to enhance transparency in IO use and wants to inform future research in IO. The trial has been registered in the German Clinical Trials Register (DRKS) under the ID DRKS00033250 and in the studyBox of the German Cancer Association under the ID ST-U173 on 18th December 2023. The trial was approved by the ethics committee of the University Medical Center Ulm under the number 375/23 on 7th December 2023.https://www.frontiersin.org/articles/10.3389/fonc.2024.1455281/fullintegrative oncologyoncology registrydemographyquality of lifeuser profileintegrative oncology consultation |
| spellingShingle | Paul G. Werthmann Paul G. Werthmann Paul G. Werthmann Ann-Kathrin Lederer Ann-Kathrin Lederer Hannah Maja Figura Klaus Kramer PRIO – a prospective integrative oncology registry: trial protocol Frontiers in Oncology integrative oncology oncology registry demography quality of life user profile integrative oncology consultation |
| title | PRIO – a prospective integrative oncology registry: trial protocol |
| title_full | PRIO – a prospective integrative oncology registry: trial protocol |
| title_fullStr | PRIO – a prospective integrative oncology registry: trial protocol |
| title_full_unstemmed | PRIO – a prospective integrative oncology registry: trial protocol |
| title_short | PRIO – a prospective integrative oncology registry: trial protocol |
| title_sort | prio a prospective integrative oncology registry trial protocol |
| topic | integrative oncology oncology registry demography quality of life user profile integrative oncology consultation |
| url | https://www.frontiersin.org/articles/10.3389/fonc.2024.1455281/full |
| work_keys_str_mv | AT paulgwerthmann prioaprospectiveintegrativeoncologyregistrytrialprotocol AT paulgwerthmann prioaprospectiveintegrativeoncologyregistrytrialprotocol AT paulgwerthmann prioaprospectiveintegrativeoncologyregistrytrialprotocol AT annkathrinlederer prioaprospectiveintegrativeoncologyregistrytrialprotocol AT annkathrinlederer prioaprospectiveintegrativeoncologyregistrytrialprotocol AT hannahmajafigura prioaprospectiveintegrativeoncologyregistrytrialprotocol AT klauskramer prioaprospectiveintegrativeoncologyregistrytrialprotocol |